This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 500g
Available purity: ≥97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 61-68-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
500g
≥97%
0
Out of Stock
Shenzhen
Inquiry
61-68-7 / 2-(2,3-dimethylanilino)benzoic acid
Standard CAS: 61-68-7
Multi CAS: Yes
Basic Information
copy
CAS
61-68-7 copy
Multi CAS
Yes copy
Molecular Formula
C15H15NO2 copy
Molecular Weight
241.280000 copy
Exact Mass
241.110279 copy
InChI
InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18) copy
InChIKey
HYYBABOKPJLUIN-UHFFFAOYSA-N copy
Physical Properties
copy
Melting Point
230-231 °C
DECARBOXYLATES @ TEMP ABOVE ITS MELTING POINT (@ 300 °C, 100% IS DECARBOXYLATED IN 3 MIN)
230 - 231 °C copy
Physical Description
Solid copy
Appearance
CRYSTALS
WHITE TO OFF-WHITE, CRYSTALLINE POWDER copy
State
Solid copy
Computed Properties
copy
Structural Parameters
Heavy atom count
18 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.13 copy
Rotatable bonds
3 copy
H-bond acceptors
2 copy
H-bond donors
2 copy
Molar refractivity
72.6 copy
TPSA
49.33 copy
LogP / Solubility
WLOGP
3.75 copy
MLOGP
3.3 copy
XLogP3
5.1 copy
Consensus LogP
4.05 copy
Log S (ESOL)
-3.99 copy
Class (ESOL)
Poorly soluble copy
Log S (Ali)
-4.24 copy
Class (Ali)
Slightly soluble copy
Log S (SILICOS-IT)
-4.7 copy
Class (SILICOS-IT)
Slightly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-1.53 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy